Published in Med J Aust on November 29, 1980
Developing an evidence-based Guide to Community Preventive Services--methods. The Task Force on Community Preventive Services. Am J Prev Med (2000) 6.43
Field evaluation of vaccine efficacy. Bull World Health Organ (1985) 4.95
Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic. JAMA (1985) 3.85
Morbidity and mortality associated with the July 1980 heat wave in St Louis and Kansas City, Mo. JAMA (1982) 3.69
Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults. The Task Force on Community Preventive Services. Am J Prev Med (2000) 3.65
Rational strategy for rubella vaccination. Lancet (1983) 3.61
Assessing vaccine efficacy in the field. Further observations. Epidemiol Rev (1988) 3.51
Immunization policies and vaccine coverage among adults. The risk for missed opportunities. Ann Intern Med (1988) 3.49
AIDS and absolutism--the demand for perfection in prevention. N Engl J Med (1992) 3.03
The opportunity and obligation to eliminate measles from the United States. JAMA (1979) 2.93
Outbreak of paralytic poliomyelitis in Oman: evidence for widespread transmission among fully vaccinated children. Lancet (1991) 2.64
The immunization system in the United States - the role of school immunization laws. Vaccine (1999) 2.57
Tuberculosis symposium: emerging problems and promise. J Infect Dis (1993) 2.55
Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. Clin Infect Dis (1992) 2.55
Patterns of transmission in measles outbreaks in the United States, 1985-1986. N Engl J Med (1989) 2.41
The sample household health interview survey. Am J Public Health (1982) 2.35
Vaccine-associated paralytic poliomyelitis. United States: 1973 through 1984. JAMA (1987) 2.28
Barriers to vaccinating preschool children. J Health Care Poor Underserved (1990) 2.26
Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine. Lancet (1993) 2.24
A persistent outbreak of measles despite appropriate prevention and control measures. Am J Epidemiol (1987) 2.13
Developing the Guide to Community Preventive Services--overview and rationale. The Task Force on Community Preventive Services. Am J Prev Med (2000) 2.10
Improving immunization coverage rates: an evidence-based review of the literature. Epidemiol Rev (1999) 2.09
Use of health services. Am J Public Health (1982) 2.06
Seroprevalence of antibody against poliovirus in inner-city preschool children. Implications for vaccination policy in the United States. JAMA (1996) 1.93
Risk factors for outbreaks of influenza in nursing homes. A case-control study. Am J Epidemiol (1986) 1.93
From the Center for Disease control: current status of measles in the United States, 1973--1977. J Infect Dis (1978) 1.91
Progress in measles elimination. JAMA (1982) 1.87
Immunization of six-month-old infants with different doses of Edmonston-Zagreb and Schwarz measles vaccines. N Engl J Med (1990) 1.82
Appropriate age for measles vaccination in the United States. Dev Biol Stand (1986) 1.80
Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization. Ann Intern Med (1994) 1.79
Low measles incidence: association with enforcement of school immunization laws. Am J Public Health (1981) 1.79
Current features of measles in the United States: feasibility of measles elimination. Epidemiol Rev (1980) 1.76
Risk of acute respiratory disease among pregnant women during influenza A epidemics. Public Health Rep (1986) 1.75
Costs of care. Am J Public Health (1982) 1.74
Costs of immunization registries: experiences from the All Kids Count II Projects. Am J Prev Med (2000) 1.72
The case for global eradication of poliomyelitis. Bull World Health Organ (1987) 1.72
Health impact of measles vaccination in the United States. Pediatrics (1985) 1.71
Mucosal immunity induced by enhance-potency inactivated and oral polio vaccines. J Infect Dis (1991) 1.66
Health services in Shanghai County: introduction to Shanghai County. Am J Public Health (1982) 1.63
Hepatitis B infection in households of chronic carriers of hepatitis B surface antigen: factors associated with prevalence of infection. Am J Epidemiol (1982) 1.60
Pertussis and pertussis vaccine. Reanalysis of benefits, risks, and costs. JAMA (1984) 1.59
Epidemiological features of pertussis in the United States, 1980-1989. Clin Infect Dis (1992) 1.55
Rubella vaccination in the United States: a ten-year review. Epidemiol Rev (1980) 1.53
Elimination of indigenous measles from the United States. Rev Infect Dis (1983) 1.50
Fetal risk associated with rubella vaccine: an update. Rev Infect Dis (1985) 1.50
Lack of significant person-to-person spread of swine influenza-like virus following fatal infection in an immunocompromised child. Am J Epidemiol (1984) 1.47
Causes of low preschool immunization coverage in the United States. Annu Rev Public Health (1992) 1.45
Resurgence of measles in New York. Am J Public Health (1972) 1.43
Surveillance. Information for action. Pediatr Clin North Am (1990) 1.43
Global progress in infectious disease control. Vaccine (1998) 1.42
Safety of prolonged administration of rimantadine hydrochloride in the prophylaxis of influenza A virus infections in nursing homes. Antimicrob Agents Chemother (1984) 1.42
The Russian flu. Its history and implications for this year's influenza season. JAMA (1978) 1.41
Evaluation of telephoned computer-generated reminders to improve immunization coverage at inner-city clinics. Public Health Rep (1993) 1.40
Pertussis--a disease and a vaccine that are not going away. West J Med (1989) 1.35
Major impediments to measles elimination. The modern epidemiology of an ancient disease. Am J Dis Child (1985) 1.32
Preparing for pandemic influenza: the need for enhanced surveillance. Emerg Infect Dis (1999) 1.32
Risk factors for community- and household-acquired pertussis during a large-scale outbreak in central Wisconsin. J Infect Dis (1988) 1.31
Structuring HIV prevention service delivery systems on the basis of social science theory. J Community Health (1992) 1.29
Nephrotoxicity associated with the use of cephaloridine. JAMA (1967) 1.29
Current poliomyelitis immunization policy in the United States. Pediatr Ann (1990) 1.28
Strategies to prevent HIV infection in the United States. Am J Public Health (1991) 1.27
Pertussis and pertussis vaccine: further analysis of benefits, risks and costs. Dev Biol Stand (1985) 1.26
Assessment of susceptibility to measles and rubella. JAMA (1982) 1.26
Universal immunization to interrupt rubella. Rev Infect Dis (1985) 1.25
A benefit-cost analysis of a childhood varicella vaccination programme. Postgrad Med J (1985) 1.24
Measles and rubella: our remaining responsibilities. Am J Public Health (1983) 1.23
Imported measles in the United States. JAMA (1982) 1.23
The case for global measles eradication. Lancet (1982) 1.23
Analysis, interpretation, use, and dissemination of surveillance information. Bull Pan Am Health Organ (1977) 1.22
The opportunity and obligation to eliminate rubella from the United States. JAMA (1984) 1.20
Abscesses complicating DTP vaccination. Am J Dis Child (1981) 1.19
Clinical efficacy of rubella vaccine. Pediatr Infect Dis (1983) 1.18
Rubella antibody persistence after immunization. Sixteen-year follow-up in the Hawaiian Islands. JAMA (1988) 1.18
A randomized controlled trial of influenza vaccine in the elderly. Scientific scrutiny and ethical responsibility. JAMA (1994) 1.17
Human immunodeficiency virus counseling, testing, referral, and partner notification services. A cost-benefit analysis. Arch Intern Med (1993) 1.16
Diphtheria-tetanus toxoids-pertussis vaccination and sudden infant deaths in Tennessee. J Pediatr (1982) 1.16
Use of influenza vaccine in nursing homes. J Am Geriatr Soc (1985) 1.14
Foodborne shigellosis at a country fair. Am J Epidemiol (1974) 1.14
Crossing the divide from vaccine technology to vaccine delivery. The critical role of providers. JAMA (1994) 1.13
Principles of measles control. Bull World Health Organ (1991) 1.13
The roles of vaccination and amantadine prophylaxis in controlling an outbreak of influenza A (H3N2) in a nursing home. Arch Intern Med (1988) 1.12
Lymphocytic choriomeningitis in university hospital personnel. Clinical features. Am J Med (1975) 1.12
Improved inactivated poliovirus vaccine: an update. Pediatr Infect Dis (1986) 1.10
Imported measles. A potential control problem. JAMA (1981) 1.10
Methods of assessing the impact of congenital rubella infection. Rev Infect Dis (1985) 1.10
Paralytic poliomyelitis in Romania, 1984-1992. Evidence for a high risk of vaccine-associated disease and reintroduction of wild-virus infection. Am J Epidemiol (1994) 1.09
Cumulative prevalence rates and corrected incidence rates of surgical sterilization among women in the United States, 1971--1978. Am J Epidemiol (1982) 1.09
From the CDC. Partner notification and confidentiality of the index patient: its role in preventing HIV. Sex Transm Dis (1990) 1.09
The effect of diarrhea on oral poliovirus vaccine failure in Brazil. J Infect Dis (1997) 1.08
Outbreak of lymphocytic choriomeningitis virus infections in medical center personnel. Am J Epidemiol (1975) 1.07
Acellular and whole-cell pertussis vaccines in Japan. Report of a visit by US scientists. JAMA (1987) 1.06
Kawasaki syndrome: association with the application of rug shampoo. Lancet (1982) 1.06